s.1manbetx

Biopharma's winners and losers of 2025

What a year! The XBI is up, M&A is bumping and the vibes are improving. But it ain’t all Christmas cookies. As has become our tradition, we kept track of who was up and who was down in 2025 to take stock of the year in ideas, people, drugs and companies.

This report was first published by Endpoints News. To see the original version, click here

What a year! The XBI is up, M&A is bumping and the vibes are improving. But it ain’t all Christmas cookies. As has become our tradition, we kept track of who was up and who was down in 2025 to take stock of the year in ideas, people, drugs and companies.

The choices on the Endpoints News winners and losers list are the product of hours of debate (really!), a highly rigorous scientific process (… not really) followed by extensive peer review. Don’t like our picks? Better luck in 2026!

您已阅读9%(577字),剩余91%(5824字)包含更多重要信息,订阅以继续探索完整内容,并享受更多专属服务。
版权声明:本文版权归Endpoints News所有,未经允许任何单位或个人不得转载,复制或以任何其他方式使用本文全部或部分,侵权必究。
设置字号×
最小
较小
默认
较大
最大
分享×